Insider Selling: GRAIL (NASDAQ:GRAL) President Sells $620,288.00 in Stock

GRAIL, Inc. (NASDAQ:GRAL) President Joshua Ofman sold 9,692 shares of GRAIL stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $64.00, for a total value of $620,288.00. Following the completion of the sale, the president owned 478,182 shares in the company, valued at approximately $30,603,648. This represents a 1.99% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

GRAIL Stock Up 1.3%

Shares of GRAIL stock opened at $65.54 on Friday. The business has a 50 day moving average of $38.69 and a 200 day moving average of $37.18. GRAIL, Inc. has a 52 week low of $12.33 and a 52 week high of $73.74. The company has a market cap of $2.36 billion, a PE ratio of -5.00 and a beta of 4.11.

GRAIL (NASDAQ:GRAL) last issued its quarterly earnings data on Tuesday, August 12th. The company reported ($3.18) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($3.14) by ($0.04). GRAIL had a negative net margin of 329.86% and a negative return on equity of 16.64%. The company had revenue of $35.54 million for the quarter, compared to analysts’ expectations of $37.57 million. On average, research analysts anticipate that GRAIL, Inc. will post -15.15 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. UBS Group set a $75.00 price objective on shares of GRAIL in a report on Friday. Canaccord Genuity Group raised their target price on GRAIL from $43.00 to $75.00 and gave the company a “buy” rating in a research note on Friday. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of GRAIL in a research report on Saturday, September 27th. One equities research analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $56.67.

Hedge Funds Weigh In On GRAIL

A number of hedge funds have recently bought and sold shares of GRAL. Teacher Retirement System of Texas lifted its stake in GRAIL by 5.5% during the 2nd quarter. Teacher Retirement System of Texas now owns 8,538 shares of the company’s stock valued at $439,000 after acquiring an additional 447 shares during the period. Parallel Advisors LLC lifted its position in GRAIL by 24.1% during the second quarter. Parallel Advisors LLC now owns 2,313 shares of the company’s stock valued at $119,000 after purchasing an additional 449 shares during the period. S.A. Mason LLC boosted its holdings in GRAIL by 50.1% in the first quarter. S.A. Mason LLC now owns 1,499 shares of the company’s stock worth $38,000 after purchasing an additional 500 shares during the last quarter. Crown Wealth Group LLC grew its position in GRAIL by 5.9% in the 2nd quarter. Crown Wealth Group LLC now owns 8,986 shares of the company’s stock worth $462,000 after purchasing an additional 500 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in GRAIL by 28.2% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,835 shares of the company’s stock valued at $76,000 after buying an additional 623 shares during the last quarter.

GRAIL Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.